OAM
RVLP

Oxford Asset Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Oxford Asset Management’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$123K Sell
38,710
-112,827
-74% -$601K 0.02% 135
2019
Q4 		$1.06M Buy
+151,537
New +$809K 0.03% 832
2019
Q1 		– Sell
-12,179
Closed -$94K – 2081
2018
Q4 		$94K Buy
+12,179
New +$97.5K ﹤0.01% 1654

Other funds holding RVLP

SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Oxford Asset Management's RVLP Position: Q1 2020 in Review

Oxford Asset Management reduced its RVL Pharmaceuticals plc Ordinary Shares (RVLP) stake by 74% in Q1 2020, selling an estimated $601K and leaving 38,710 shares worth $123K. The position accounts for 0.02% of the portfolio, ranked #135.

Oxford Asset Management first reported a position in RVLP in Q4 2018 and has held it in 3 quarters since. The position peaked at $1.06M in Q4 2019. 62 funds tracked by Wall St. Rank hold RVLP as of Q1 2020.

  • Oxford Asset Management held 38,710 shares of RVL Pharmaceuticals plc Ordinary Shares worth $123K as of Q1 2020.
  • Oxford Asset Management sold 112,827 RVL Pharmaceuticals plc Ordinary Shares shares in Q1 2020, an estimated $601K.
  • RVL Pharmaceuticals plc Ordinary Shares made up 0.02% of Oxford Asset Management's portfolio in Q1 2020, its #135 holding.
  • Oxford Asset Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2018 and has held it in 3 quarters since.
  • Oxford Asset Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $1.06M in Q4 2019.
  • 62 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.